S&P 500   2,675.92 (+0.46%)
DOW   22,783.34 (+0.46%)
QQQ   197.37 (+0.45%)
AAPL   260.58 (-0.72%)
FB   169.14 (+2.17%)
MSFT   164.92 (-0.22%)
GOOGL   1,189.02 (+0.49%)
AMZN   2,012.46 (+0.74%)
NVDA   258.67 (-3.63%)
BABA   197.57 (+0.57%)
MU   46.52 (+0.32%)
GE   7.02 (-2.90%)
TSLA   542.40 (+5.07%)
AMD   47.62 (+0.21%)
T   30.16 (+2.45%)
ACB   0.80 (+0.00%)
F   4.66 (+2.87%)
NFLX   372.85 (-1.87%)
BAC   22.12 (+3.37%)
GILD   74.49 (-4.17%)
DIS   100.82 (+1.24%)
S&P 500   2,675.92 (+0.46%)
DOW   22,783.34 (+0.46%)
QQQ   197.37 (+0.45%)
AAPL   260.58 (-0.72%)
FB   169.14 (+2.17%)
MSFT   164.92 (-0.22%)
GOOGL   1,189.02 (+0.49%)
AMZN   2,012.46 (+0.74%)
NVDA   258.67 (-3.63%)
BABA   197.57 (+0.57%)
MU   46.52 (+0.32%)
GE   7.02 (-2.90%)
TSLA   542.40 (+5.07%)
AMD   47.62 (+0.21%)
T   30.16 (+2.45%)
ACB   0.80 (+0.00%)
F   4.66 (+2.87%)
NFLX   372.85 (-1.87%)
BAC   22.12 (+3.37%)
GILD   74.49 (-4.17%)
DIS   100.82 (+1.24%)
S&P 500   2,675.92 (+0.46%)
DOW   22,783.34 (+0.46%)
QQQ   197.37 (+0.45%)
AAPL   260.58 (-0.72%)
FB   169.14 (+2.17%)
MSFT   164.92 (-0.22%)
GOOGL   1,189.02 (+0.49%)
AMZN   2,012.46 (+0.74%)
NVDA   258.67 (-3.63%)
BABA   197.57 (+0.57%)
MU   46.52 (+0.32%)
GE   7.02 (-2.90%)
TSLA   542.40 (+5.07%)
AMD   47.62 (+0.21%)
T   30.16 (+2.45%)
ACB   0.80 (+0.00%)
F   4.66 (+2.87%)
NFLX   372.85 (-1.87%)
BAC   22.12 (+3.37%)
GILD   74.49 (-4.17%)
DIS   100.82 (+1.24%)
S&P 500   2,675.92 (+0.46%)
DOW   22,783.34 (+0.46%)
QQQ   197.37 (+0.45%)
AAPL   260.58 (-0.72%)
FB   169.14 (+2.17%)
MSFT   164.92 (-0.22%)
GOOGL   1,189.02 (+0.49%)
AMZN   2,012.46 (+0.74%)
NVDA   258.67 (-3.63%)
BABA   197.57 (+0.57%)
MU   46.52 (+0.32%)
GE   7.02 (-2.90%)
TSLA   542.40 (+5.07%)
AMD   47.62 (+0.21%)
T   30.16 (+2.45%)
ACB   0.80 (+0.00%)
F   4.66 (+2.87%)
NFLX   372.85 (-1.87%)
BAC   22.12 (+3.37%)
GILD   74.49 (-4.17%)
DIS   100.82 (+1.24%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 XBiotechBioXcel TherapeuticsMacroGenicsCrinetics PharmaceuticalsNeoleukin Therapeutics
SymbolNASDAQ:XBITNASDAQ:BTAINASDAQ:MGNXNASDAQ:CRNXNASDAQ:NLTX
Price Information
Current Price$12.23$20.38$5.38$13.16$10.00
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$23.00$51.00$18.91$36.00$19.50
% Upside from Price Target88.06% upside150.25% upside251.47% upside173.56% upside95.00% upside
Trade Information
Market Cap$373.61 million$406.02 million$276.11 million$324.04 million$387.57 million
Beta1.131.532.191.36-4.85
Average Volume394,646572,889705,151102,165358,004
Sales & Book Value
Annual RevenueN/AN/A$64.19 million$1.19 million$25 million
Price / SalesN/AN/A4.12271.7215.35
Cashflow$17.23 per shareN/AN/AN/AN/A
Price / Cash0.71N/AN/AN/AN/A
Book Value$18.20 per share$1.49 per share$4.71 per share$4.84 per share$2.91 per share
Price / BookN/AN/A1.142.723.44
Profitability
Net Income$668.63 million$-32,970,000.00$-151,810,000.00$-50,420,000.00$-69,440,000.00
EPS($0.59)($2.02)($3.16)($2.09)($0.75)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio53.17N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-236.51%N/AN/A
Return on Equity (ROE)288.62%-110.97%-55.16%-37.27%-24.66%
Return on Assets (ROA)268.74%-85.25%-41.53%-33.91%-23.75%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.04%0.12%0.04%N/A
Current Ratio11.90%4.03%5.31%14.79%30.27%
Quick Ratio11.90%4.03%5.31%14.79%30.28%
Ownership Information
Institutional Ownership Percentage13.30%21.53%92.87%85.10%50.49%
Insider Ownership Percentage33.40%64.80%7.88%7.40%7.10%
Miscellaneous
Employees5618364478
Shares Outstanding28.85 million20.18 million49.13 million24.57 million38.37 million
Next Earnings Date5/14/2020 (Estimated)5/5/2020 (Estimated)5/6/2020 (Estimated)5/11/2020 (Estimated)5/5/2020 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel